Benzinga | Aug 11, 2020 11:55AM EDT

HC Wainwright & Co. Maintains Buy on Paratek Pharmaceuticals, Raises Price Target to $19

HC Wainwright & Co. maintains Paratek Pharmaceuticals (NASDAQ:PRTK) with a Buy and raises the price target from $18 to $19.